1ry Versus 2ry ILM Peeling in RD
Primary Versus Secondary Internal Limiting Membrane Peeling in Uncomplicated Retinal Detachment
1 other identifier
interventional
100
1 country
1
Brief Summary
Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be classified into two groups according to the timing of ILM peeling. Group A, ILM peelin will be performed during the first intervention, while in group B, it will be done at the time of silicon oil extraction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
January 6, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
January 16, 2026
January 1, 2026
12 months
January 6, 2026
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of complications
From enrollment till 3 months postoperative
Study Arms (2)
Group A (Primary ILM peeling)
ACTIVE COMPARATORILM peeling during PPV for rRD
Group B
ACTIVE COMPARATORILM peeling at time of silicon oil extraction
Interventions
ILM peeling during the 1st surgical intervention for rRD
Eligibility Criteria
You may qualify if:
- Patients with uncomplicated rhegmatogenous retinal detcahment.
You may not qualify if:
- PVR
- Recurrent RD
- Tractional RD
- Macular hole RD
- Scleral buckling is indicated
- Macular scarring
- Previous PPV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag Faculty of Medicine
Sohag, Sohag Governorate, 82511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology
Study Record Dates
First Submitted
January 6, 2026
First Posted
January 16, 2026
Study Start
December 15, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- From enrollment and forever.
All IPD will be available for other researchers.